Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

被引:32
作者
Canal, Berta [1 ]
McClure, Allison W. [1 ]
Curran, Joseph F. [2 ]
Wu, Mary [4 ]
Ulferts, Rachel [3 ]
Weissmann, Florian [1 ]
Zeng, Jingkun [1 ]
Bertolin, Agustina P. [1 ]
Milligan, Jennifer C. [1 ]
Basu, Souradeep [2 ]
Drury, Lucy S. [1 ]
Deegan, Tom D. [5 ]
Fujisawa, Ryo [5 ]
Roberts, Emma L. [2 ]
Basier, Clovis [2 ]
Labib, Karim [5 ]
Beale, Rupert [3 ]
Howell, Michael [4 ]
Diffley, John F. X. [1 ]
机构
[1] Francis Crick Inst, Chromosome Replicat Lab, 1 Midland Rd, London NW1 1AT, England
[2] Francis Crick Inst, Cell Cycle Lab, 1 Midland Rd, London NW1 1AT, England
[3] Francis Crick Inst, Cell Biol Infect Lab, 1 Midland Rd, London NW1 1AT, England
[4] Francis Crick Inst, High Throughput Screening, 1 Midland Rd, London NW1 1AT, England
[5] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland
基金
英国惠康基金; 英国医学研究理事会;
关键词
AURINTRICARBOXYLIC ACID; SELECTIVE-INHIBITION; VIRUS-REPLICATION; RNA VIRUS; CORONAVIRUS; PROTEIN; COMPLEX; PATULIN; NSP14; POLYMERASE;
D O I
10.1042/BCJ20210198
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across the world causing a deadly pandemic with tremendous social and economic costs. Healthcare systems worldwide are under great pressure, and there is an urgent need for effective antiviral treatments. The only currently approved antiviral treatment for COVID-19 is remdesivir, an inhibitor of viral genome replication. SARS-CoV-2 proliferation relies on the enzymatic activities of the non-structural proteins (nsp), which makes them interesting targets for the development of new antiviral treatments. With the aim to identify novel SARS-CoV-2 antivirals, we have purified the exoribonuclease/methyltransferase (nsp14) and its cofactor (nsp10) and developed biochemical assays compatible with highthroughput approaches to screen for exoribonuclease inhibitors. We have screened a library of over 5000 commercial compounds and identified patulin and aurintricarboxylic acid (ATA) as inhibitors of nsp14 exoribonuclease in vitro. We found that patulin and ATA inhibit replication of SARS-CoV-2 in a VERO E6 cell-culture model. These two new antiviral compounds will be valuable tools for further coronavirus research as well as potentially contributing to new therapeutic opportunities for COVID-19.
引用
收藏
页码:2445 / 2464
页数:20
相关论文
共 76 条
[1]   Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [J].
Agostini, Maria L. ;
Andres, Erica L. ;
Sims, Amy C. ;
Graham, Rachel L. ;
Sheahan, Timothy P. ;
Lu, Xiaotao ;
Smith, Everett Clinton ;
Case, James Brett ;
Feng, Joy Y. ;
Jordan, Robert ;
Ray, Adrian S. ;
Cihlar, Tomas ;
Siegel, Dustin ;
Mackman, Richard L. ;
Clarke, Michael O. ;
Baric, Ralph S. ;
Denison, Mark R. .
MBIO, 2018, 9 (02)
[2]   Drug repositioning: Identifying and developing new uses for existing drugs [J].
Ashburn, TT ;
Thor, KB .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) :673-683
[3]  
Baddock H. T., 2020, BIORXIV, V2429, DOI DOI 10.1101/2020.08.13.248211
[4]   Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase [J].
Basu, Souradeep ;
Mak, Tiffany ;
Ulferts, Rachel ;
Wu, Mary ;
Deegan, Tom ;
Fujisawa, Ryo ;
Tan, Kang Wei ;
Lim, Chew Theng ;
Basier, Clovis ;
Canal, Berta ;
Curran, Joseph F. ;
Drury, Lucy S. ;
McClure, Allison W. ;
Roberts, Emma L. ;
Weissmann, Florian ;
Zeisner, Theresa U. ;
Beale, Rupert ;
Cowling, Victoria H. ;
Howell, Michael ;
Labib, Karim ;
Diffley, John F. X. .
BIOCHEMICAL JOURNAL, 2021, 478 (01) :2481-2497
[5]   Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response [J].
Becares, Martina ;
Pascual-Iglesias, Alejandro ;
Nogales, Aitor ;
Sola, Isabel ;
Enjuanes, Luis ;
Zuniga, Sonia .
JOURNAL OF VIROLOGY, 2016, 90 (11) :5399-5414
[6]  
Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]
[7]   Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase [J].
Bertolin, Agustina P. ;
Weissmann, Florian ;
Zeng, Jingkun ;
Posse, Viktor ;
Milligan, Jennifer C. ;
Canal, Berta ;
Ulferts, Rachel ;
Wu, Mary ;
Drury, Lucy S. ;
Howell, Michael ;
Beale, Rupert ;
Diffley, John F. X. .
BIOCHEMICAL JOURNAL, 2021, 478 (01) :2425-2443
[8]   Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 [J].
Blanco-Melo, Daniel ;
Nilsson-Payant, Benjamin E. ;
Liu, Wen-Chun ;
Uhl, Skyler ;
Hoagland, Daisy ;
Moller, Rasmus ;
Jordan, Tristan X. ;
Oishi, Kohei ;
Panis, Maryline ;
Sachs, David ;
Wang, Taia T. ;
Schwartz, Robert E. ;
Lim, Jean K. ;
Albrecht, Randy A. ;
tenOever, Benjamin R. .
CELL, 2020, 181 (05) :1036-+
[9]   Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes [J].
Bouvet, Mickael ;
Lugari, Adrien ;
Posthuma, Clara C. ;
Zevenhoven, Jessika C. ;
Bernard, Stephanie ;
Betzi, Stephane ;
Imbert, Isabelle ;
Canard, Bruno ;
Guillemot, Jean-Claude ;
Lecine, Patrick ;
Pfefferle, Susanne ;
Drosten, Christian ;
Snijder, Eric J. ;
Decroly, Etienne ;
Morelli, Xavier .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (37) :25783-25796
[10]   RNA 3′-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex [J].
Bouvet, Mickael ;
Imbert, Isabelle ;
Subissi, Lorenzo ;
Gluais, Laure ;
Canard, Bruno ;
Decroly, Etienne .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (24) :9372-9377